Evidence map›Paper›PMID 42170172›Full record

ArticleFrontiers in immunology2026

VEXAS Syndrome for the laboratory physician: a case report.

Chaoying Chen, Miaomiao Chen, Tieqiao Chen, Yong Chen, Lingzhi Liu, Yixi Zhu, Xiaoming Yi, Shuguang He

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chaoying ChenDepartment of Laboratory Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medical College (Hunan Provincial Directly Affiliated Hospital of Traditional Chinese Medicine), Zhuzhou, China.
Miaomiao ChenDepartment of Radiology, Zhuzhou Central Hospital, Zhuzhou, China.
Tieqiao ChenDepartment of Laboratory Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medical College (Hunan Provincial Directly Affiliated Hospital of Traditional Chinese Medicine), Zhuzhou, China.
Yong ChenDepartment of Radiology, The First Affiliated Hospital of Hunan Traditional Chinese Medical College (Hunan Provincial Directly Affiliated Hospital of Traditional Chinese Medicine), Zhuzhou, China.
Lingzhi LiuDepartment of Laboratory Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medical College (Hunan Provincial Directly Affiliated Hospital of Traditional Chinese Medicine), Zhuzhou, China.
Yixi ZhuDepartment of Laboratory Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medical College (Hunan Provincial Directly Affiliated Hospital of Traditional Chinese Medicine), Zhuzhou, China.
Xiaoming YiDepartment of Laboratory Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medical College (Hunan Provincial Directly Affiliated Hospital of Traditional Chinese Medicine), Zhuzhou, China.
Shuguang HeDepartment of Laboratory Medicine, The First Affiliated Hospital of Hunan Traditional Chinese Medical College (Hunan Provincial Directly Affiliated Hospital of Traditional Chinese Medicine), Zhuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome represents a recently identified systemic condition, and its diagnosis and management carry significant clinical ramifications. Despite advancements in understanding the clinical features and pathological mechanisms associated with this syndrome, challenges related to underdiagnosis persist. To date, there have been no reported large-scale prospective studies on this syndrome, and effective, sustained treatment strategies remain undeveloped, contributing to the poor overall prognosis. Consequently, it is crucial to enhance the awareness of this syndrome, delineate its clinical characteristics and associated laboratory indicators, and bolster the capacity for early identification and diagnosis. Methods: This case report seeks to examine the diagnostic approach to VEXAS syndrome from a laboratory technician's standpoint, underscoring the necessity for early recognition. Results: The patient in this case exhibited characteristic clinical manifestations, including fever, rash, arthritis, and hematological irregularities. The diagnosis of VEXAS syndrome was established in conjunction with pertinent laboratory findings. Discussion: Through this report, we aim to advance the understanding of VEXAS syndrome and enhance the proficiency of laboratory physicians in recognizing the condition in their routine practice, thereby facilitating early diagnosis and treatment for patients and improving overall prognostic outcomes.

Indexed as

Hereditary Autoinflammatory DiseasesCase Reports as TopicHumansMaleMyelodysplastic SyndromesSkin Diseases, Geneticautoinflammatory diseasebone marrow cellscase reportearly diagnosislaboratory personnelvacuolesVEXAS syndrome

Identifiers

PMID42170172
PMCPMC13187753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.